Skip to main content
. Author manuscript; available in PMC: 2009 Sep 14.
Published in final edited form as: Brain Stimul. 2008 Apr 1;1(2):71–83. doi: 10.1016/j.brs.2008.03.001

Table 5.

Short-term Effects of ECT on Cognitive Measures, According to Treatment Group.*

Ultrabrief
Right
Unilateral
ECT
Ultrabrief
Bilateral
ECT
Brief Pulse
Right
Unilateral
ECT
Brief
Pulse
Bilateral
ECT
PW EP EPxPW No. of
Treatments
Age Baseline
Score
Global Cognitive Status: Modified Mini-Mental State Exam
Post-Six ECT +0.0±1.1a −0.1±0.9a −1.3±1.9b −1.0±1.7b 24.4 0.2 0.8 2.1 55.9
Post-Treatment Course +0.2±1.0a −0.2±1.0b −0.6±1.2b −0.6±1.1b 13.2§ 1.8 2.2 0.0 5.3 47.1
Anterograde Memory: Delayed Reproduction Complex Figure Test
Post-Six ECT −0.1±0.9a −0.1±0.9a −0.3±0.8a,b −0.5±0.6b 4.3 0.1 0.4 0.5 30.2
Post-Treatment Course +0.2±1.0a +0.1±0.8a −0.3±0.9b −0.4±0.7b 11.4§ 0.4 0.1 3.4 0.1 40.5
Anterograde Memory: Delayed Recall Buschke Selective Reminding Test
Post-Six ECT +0.4±1.1a +0.3±0.9a −0.4±1.0b −0.3±0.7b 18.3 0.2 0.4 1.9 37.2
Post-Treatment Course +0.3±1.0a +0.2±0.9a,b −0.2±1.2b −0.1±0.7b 5.6 0.3 0.1 0.4 0.3 33.3
Anterograde Memory: Randt Story Recall at 24 Hr Delay
Post-Six ECT −0.2±0.9 −0.3±1.2 −0.9±0.7 −0.7±1.1 4.5 0.3 0.3 0.7 11.4§
Post-Treatment Course +0.1±1.1a −0.2±1.2a,b −0.6±0.8a,b −0.7±1.2b 4.7 0.4 0.1 1.7 0.0 12.4§
Retrograde Memory: Autobiographical Memory Interview
Post-Treatment Course 0.0±1.0a −0.4±1.1b −1.0±1.0c −1.4±1.0d 44.7 10.0 0.0 31.6 1.7 81.9
Retrograde Memory: Goldberg Public Events
Post-Treatment Course 0.0±1.2a −0.2±0.9a −0.2±1.2a −0.6±1.0b 9.8 9.4 1.5 2.7 0.1 264.4
Subjective Cognitive Evaluation
Global Memory Assessment −0.3±1.0a −1.1±0.9b −1.4±1.0b −1.4±1.0b 15.8§ 7.5 0.7 8.6 10.0
*

Plus–minus values are means±SD. PW is the F-value for the main effect of pulse width from the ANCOVA. EP is F-value for the main effect of electrode placement. EPxPW is the F-value for the interaction between pulse width and electrode placement. No. of Treatments is the F-value for the covariate, number of ECT treatments. Age is the F-value for the covariate, patient age. For all measures lower values indicate greater impairment. Values with different letter superscripts differed significantly from each other in post hoc t-tests on least-squares adjusted means (P<0.05).

F-value was significant in the ANCOVA (P<0.05)

F-value was significant in the ANCOVA (P<0.01)

§

F-value was significant in the ANCOVA (P<0.001)

F-value was significant in the ANCOVA (P<0.0001).

Declared a priori as a primary outcome measure.